Patent · US Active

Nilotinib HCl crystalline forms

US8592442B2 · kind B2 · utility

10Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2012
Grant dateNov 26, 2013
Priority date—
Expiry dateJun 27, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline forms of Nilotinib HCl are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.